acut
respiratori
infect
ari
real
public
health
problem
high
morbid
mortal
black
et
al
world
health
organ
classifi
respiratori
infect
second
lead
caus
death
worldwid
children
age
five
bryce
et
al
approxim
million
children
worldwid
die
year
ari
nearli
death
occur
africa
limit
diagnost
capac
william
et
al
shown
viral
infect
play
major
role
occurr
ari
develop
countri
subsaharan
africa
work
specif
virus
influenza
inf
human
respiratori
syncyti
virus
hrsv
realiz
data
occurr
ari
remain
insuffici
tiveljunglindel
et
al
brittainlong
et
al
inde
respons
virus
influenza
occurr
ari
yet
suffici
document
intern
multicent
studi
coordin
board
scienc
technolog
intern
develop
nation
academi
scienc
unit
state
found
viral
etiolog
ari
develop
countri
present
higher
proport
bacteri
etiolog
recent
studi
done
kenya
cameroon
seneg
highlight
high
preval
pathogen
ari
berkley
et
al
njouom
et
al
niang
et
al
especi
children
respiratori
virus
frequent
associ
ari
includ
inf
b
hrsv
enterovirus
env
human
metapneumoviru
hmpv
rhinoviru
hrv
adenoviru
parainfluenza
viru
piv
type
pretoriu
et
al
razanajatovo
et
al
virus
respons
sever
clinic
form
common
viral
infect
bronchiol
pneumonia
laryng
asthma
puzelli
et
al
howev
etiolog
pathogen
sought
practic
due
underestim
involv
ari
lack
adapt
laboratori
diagnosi
capac
limit
treatment
option
control
children
morbid
mortal
base
better
understand
epidemiolog
diseas
avail
adequ
laboratori
diagnosi
capac
ivoir
sentinel
surveil
system
influenza
virus
establish
initi
institut
pasteur
cote
ivoir
surveil
help
identifi
character
circul
season
influenza
influenza
b
virus
virus
circul
throughout
year
peak
vari
accord
occurr
raini
season
month
may
june
surveil
system
contribut
identifi
age
group
high
risk
sever
influenza
diseas
kadjo
et
al
along
circul
influenza
virus
respiratori
virus
detect
patient
present
ili
given
limit
resourc
laboratori
diagnosi
respiratori
virus
retrospect
limit
children
five
year
old
part
prepar
influenza
pandem
technic
capac
laboratori
strengthen
tool
molecular
diagnosi
staff
train
regular
suppli
reagent
consum
cooper
agreement
us
cdc
influenza
divis
atlanta
institut
pasteur
pari
therefor
seem
appropri
context
add
surveil
respiratori
virus
influenza
surveil
network
studi
aim
describ
epidemiolog
virolog
pattern
ari
due
noninfluenza
respiratori
virus
children
five
year
age
ivoir
patient
enrol
influenza
sentinel
surveil
network
figur
network
network
compos
sentinel
site
distribut
differ
geograph
region
countri
everi
day
doctor
nurs
train
healthcar
staff
identifi
children
meet
ili
sari
case
definit
time
studi
accord
ili
case
defin
patient
fever
temperatur
sudden
onset
cough
last
less
ten
day
sari
case
defin
patient
acut
respiratori
infect
histori
fever
fever
temperatur
cough
onset
symptom
within
ten
day
whose
condit
requir
hospit
case
sari
elig
inclus
parent
legal
guardian
gave
verbal
consent
howev
ili
first
three
case
day
enrol
site
obtain
verbal
consent
parent
legal
guardian
child
collect
specimen
first
three
case
day
subsequ
case
meet
case
definit
ili
count
record
report
weekli
summari
patient
meet
case
definit
verbal
consent
parent
legal
guardian
obtain
exclud
studi
structur
standard
questionnair
collect
sociodemograph
epidemiolog
clinic
data
develop
use
questionnair
also
includ
collect
outcom
data
risk
factor
relat
sever
influenza
viru
infect
asthma
chronic
lung
diseas
hepat
diabet
malnutrit
obes
heart
diseas
chronic
kidney
diseas
blood
disord
immun
defici
eg
hiv
infect
mertz
et
al
gill
et
al
sampl
patient
includ
studi
collect
use
steril
nasopharyng
swab
place
viral
transport
medium
vtm
mem
gibcobrl
life
technolog
paisley
scotland
penicillin
u
ml
streptomycin
mg
ml
biowhittak
mycostatin
sigma
bovin
serum
albumin
merck
darmstadt
germani
collect
sampl
place
cooler
transport
immediatli
nation
influenza
center
nic
locat
institut
pasteur
ivoir
site
locat
abidjan
store
refriger
sentinel
site
transport
nic
twice
week
maximum
storag
period
site
exceed
day
rna
extract
collect
nasopharyng
secret
put
vtm
extract
perform
use
qiaamp
viral
rna
mini
kit
hilden
germani
rna
elut
final
volum
nucleas
free
water
includ
extract
run
neg
control
two
aliquot
extract
rna
made
one
aliquot
use
pcr
second
store
futur
analys
influenza
virus
b
yamagata
victoria
lineag
detect
real
time
rtpcr
use
primer
probe
provid
cdc
intern
reagent
resourc
irr
detect
virus
mention
three
differ
amplif
kit
use
cdc
influenza
viru
real
time
rtpcr
influenza
ab
type
panel
ruo
cdc
influenza
viru
realtim
rtpcr
influenza
subtyp
panel
ruo
cdc
influenza
b
lineag
genotyp
panel
ruo
accord
cdc
real
time
rtpcr
qrtpcr
protocol
detect
character
influenza
neg
specimen
test
respiratori
virus
three
multiplex
convent
rtpcr
assay
use
describ
bellaupujol
et
al
bellaupujol
et
al
test
specimen
neg
influenza
diagnost
multiplex
human
hrsv
andhmpv
multiplex
target
parainfluenza
virus
multiplex
target
human
coronavirus
hcov
influenza
c
rhinoviru
hrv
enteroviru
env
heminest
singleplex
pcr
use
detect
hrv
differ
primer
use
amplif
list
tabl
master
mix
reagent
qiagen
onestep
rtpcr
cat
use
accord
manufactur
recommend
heminest
done
amplitaq
recombin
buffer
appli
biosystemapplera
ref
dntp
set
deoxynucleotid
pcr
grade
roch
ref
multiplex
posit
control
provid
virolog
laboratori
clemenceau
univers
teach
hospit
caen
franc
use
rtpcr
cycl
condit
min
min
follow
cycl
sec
sec
follow
final
pcr
system
appli
biosystem
amplifi
product
visual
electrophoresi
ethidium
bromid
stain
agaros
gel
agaros
electrophoresi
grade
ultra
pure
invitrogen
data
collect
store
gener
databas
use
epi
info
softwar
analyz
epidemiolog
clinic
ili
sari
data
well
associ
comorbid
data
statist
data
analysi
perform
use
r
softwar
version
averag
compar
use
tstudent
test
use
analysi
varianc
anova
two
averag
otherwis
nonparametr
kruskal
walli
test
use
varianc
studi
variabl
homogen
across
subgroup
proport
compar
use
fisher
exact
test
univari
analysi
logist
regress
use
multivari
analysi
type
error
set
period
januari
decemb
specimen
patient
five
year
age
collect
sentinel
surveil
network
among
specimen
posit
influenza
studi
focus
specimen
neg
influenza
averag
age
children
studi
popul
month
median
age
equal
month
among
popul
children
male
sex
ratio
repres
age
group
children
month
averag
age
significantli
differ
accord
gender
month
vs
men
pvalu
p
threequart
patient
came
sentinel
site
locat
capit
citi
abidjan
among
sampl
analyz
posit
least
one
pathogen
test
sixti
percent
posit
case
found
children
age
month
patient
sampl
test
posit
significantli
younger
test
neg
month
vs
month
pvalu
p
probabl
child
month
develop
respiratori
infect
influenza
time
higher
child
p
tabl
among
posit
case
follow
agent
detect
order
frequenc
hrhv
hrsv
piv
hmpv
env
codetect
two
virus
observ
case
parainfluenza
virus
frequent
detect
codetect
case
case
distribut
follow
rsv
virus
target
three
multiplex
pcr
detect
age
group
month
detect
rate
differ
virus
also
highest
age
group
hrhv
piv
hrsv
hmpv
detect
age
group
env
detect
age
group
month
tabl
patient
classifi
two
clinic
present
group
ili
sari
among
sampl
analyz
ili
case
sari
case
proport
patient
infect
least
one
viru
ili
case
sari
case
statist
signific
differ
two
group
group
highest
posit
rate
observ
children
age
rang
month
detect
viru
ili
posit
case
rhinoviru
hrsv
sari
posit
case
case
tabl
among
patient
infect
sever
risk
factor
relat
clinic
histori
risk
factor
present
ili
case
sari
case
proport
sari
case
risk
factor
significantli
higher
sari
case
without
risk
factor
pvalu
p
asthma
present
risk
factor
case
follow
malnutrit
chronic
lung
diseas
obes
asthma
found
sari
case
risk
factor
children
risk
factor
half
posit
rsv
posit
hmpv
present
codetect
circul
respiratori
virus
greater
first
half
year
proport
posit
case
first
semest
second
half
ic
p
valu
howev
individu
trend
virus
case
hrv
infect
occur
throughout
year
month
januari
may
demonstr
highest
number
hrv
infect
detect
viru
pic
observ
month
march
similar
trend
occur
parainfluenza
viru
viru
detect
month
januari
june
high
circul
hrsv
hmpv
occur
month
june
decemb
circul
virus
coronaviru
enteroviru
occur
month
march
may
june
novemb
figur
first
studi
describ
circul
throughout
year
respiratori
virus
influenza
associ
patient
less
year
ili
sari
case
cote
ivoir
demonstr
contribut
respiratori
diseas
age
group
present
studi
target
eleven
respiratori
virus
involv
human
respiratori
infect
global
detect
rate
virus
studi
result
consist
result
sever
previou
studi
found
percentag
yang
et
al
ren
et
al
pierang
et
al
arbefevil
ferrieri
lower
report
sever
studi
africa
countri
region
world
percentag
viru
detect
rang
pretoriu
et
al
lekanadouki
et
al
ahm
et
al
differ
observ
rate
viral
etiolog
could
explain
sever
factor
relat
differ
studi
popul
geograph
catchment
area
inclus
criteria
target
virus
diagnost
techniqu
primer
use
choudhari
et
al
ali
et
al
conduct
studi
convent
pcr
method
avail
laboratori
screen
respiratori
virus
recent
year
sensit
diagnost
test
detect
respiratori
virus
greatli
improv
develop
multiplex
real
time
pcr
protocol
high
sensit
target
major
respiratori
virus
involv
human
patholog
barratt
et
al
zhao
et
al
malhotra
et
al
use
convent
pcr
could
thu
one
main
limit
studi
explain
larg
extent
overal
viru
detect
rate
report
studi
howev
note
better
understand
involv
respiratori
virus
respiratori
infect
children
would
interest
standard
studi
protocol
common
virus
detect
studi
rhinoviru
hrsv
account
almost
case
other
report
virus
previous
major
etiolog
respiratori
viral
infect
children
five
razanajatovo
et
al
kumar
et
al
buecher
et
al
posit
rate
found
rsv
studi
consist
previous
publish
result
kadjo
et
al
age
distribut
studi
indic
infant
whose
age
rang
year
like
infect
rhinoviru
hrsv
result
also
show
viral
pathogen
detect
piv
impli
piv
play
import
role
children
respiratori
mention
henrickson
kj
al
similar
find
obtain
studi
conduct
sever
countri
africa
lekanadouki
et
al
lagar
et
al
human
metapneumoviru
proven
one
main
viral
pathogen
respons
respiratori
infect
howev
preval
case
acut
respiratori
infect
children
remain
low
attest
result
studi
previou
studi
conduct
cote
ivoir
subsaharan
africa
region
njouom
et
al
kadjo
et
al
lekanadouki
et
al
result
metaanalysi
studi
articl
hmpv
preval
data
shown
case
among
ari
case
gill
et
al
rate
detect
studi
found
low
rate
detect
coronavirus
accord
mcintosh
et
al
global
incid
lrti
due
hcov
higher
howev
studi
shown
preval
coronaviru
pediatr
patient
significantli
higher
vari
discrep
could
attribut
differ
research
methodolog
parainfluenza
virus
frequent
pathogen
detect
dual
detect
case
data
corrobor
assert
virus
commonli
involv
codetect
virus
highest
incid
gradi
et
al
clinic
point
view
studi
show
respiratori
virus
found
case
ili
sari
children
high
proport
search
respiratori
virus
case
acut
respiratori
infect
systemat
tropic
diagnost
approach
empir
orient
bacteri
etiolog
today
access
widespread
pcr
research
integr
clinician
diagnost
approach
particularli
infant
viral
infect
lead
sever
form
respiratori
infect
especi
presenc
risk
factor
inde
attest
studi
children
risk
factor
present
sever
acut
respiratori
infect
relat
viral
infect
predomin
virus
case
hrsv
rate
hrsv
also
involv
virus
sari
case
case
correl
well
result
sever
studi
show
hrsv
common
caus
lower
respiratori
tract
infect
children
admit
hospit
nair
h
et
al
studi
show
high
proport
asthma
patient
histori
risk
factor
accord
recent
systemat
review
use
molecular
techniqu
respiratori
virus
detect
around
asthma
exacerb
highest
preval
children
papadopoulo
johnston
obviou
prevent
measur
time
manag
viral
infect
children
includ
children
histori
asthma
reduc
exacerb
seizur
progress
sever
form
viral
infect
among
virus
detect
three
season
profil
first
profil
virus
high
circul
first
semest
year
hrv
piv
virus
high
circul
second
semest
year
rsv
hmpv
group
virus
sporad
circul
env
interestingli
circul
hrhv
piv
well
correl
dri
season
occur
month
januari
may
fig
result
show
signific
associ
proport
posit
case
hrv
piv
virus
dri
season
pvalu
also
observ
proport
hrsv
posit
case
raini
season
pvalu
associ
hrsv
raini
season
put
evid
sever
studi
conduct
tropic
area
lekanadouki
et
al
et
al
transmiss
pattern
hrsv
observ
promiscu
raini
season
play
key
role
high
incid
hrsv
raini
season
find
present
studi
provid
better
understand
viru
distribut
among
differ
pediatr
age
gender
season
cote
ivoir
though
influenza
virus
repres
major
caus
ari
also
appropri
extend
influenza
surveil
respiratori
virus
better
understand
epidemiolog
burden
viral
respiratori
infect
especi
children
age
five
particularli
set
like
subsaharan
africa
still
limit
capac
molecular
diagnosi
respiratori
virus
furthermor
initi
assist
polici
maker
evalu
benefit
introduc
prevent
treatment
strategi
